NVO (NYSE) - Novo Nordisk A/S
Exchange: USA Stocks • Country: Denmark • Currency: USD • Type: Common Stock • ISIN: US6701002056
https://www.novonordisk.com
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Web URL: Drawdown (Underwater) Chart

External Links for NVO (NYSE) - Novo Nordisk...
Warnings
- Uncommon Growth Rate
Classification
Market Cap in USD | 446,463m |
Sector | Healthcare |
Industry | Biotechnology |
GiC SubIndustry | Pharmaceuticals |
TER | 0.00% |
IPO / Inception | 1982-01-04 |
Ratings
Fundamental | 9.14 |
Dividend | 8.89 |
Performance 5y | 9.40 |
Rel. Performance vs Sector | 1.56 |
Analysts | 3.75 |
Fair Price Total Ret. | 110.69 |
Fair Price DCF | todo |
Technical
Growth TTM | 94.75% |
CAGR 5y | 35.19% |
CAGR / Mean Drawdown 5y | 7.18 |
Sharpe Ratio TTM | 2.99 |
Alpha vs SP500 TTM | 81.77 |
Beta vs SP500 5y weekly | 0.68 |
CAPM | 6.83% |
Average Daily Range 2m | 1.81% |
Reversal Oscillator | 14.93 |
Volatility GJR Garch 1y | 25.42% |
Price / SMA 50 | 2.21% |
Price / SMA 200 | 16.96% |
Current Volume | 2940k |
Average Volume 20d | 4439k |
Dividends
Yield TTM | 2.24% |
Yield on Cost 5y | 10.08% |
Dividends CAGR 5y | 23.84% |
Consistency of Dividends all time | 85.2% |